Maternal RSV vaccine reduces infant RSV-associated hospitalizations by 80% through six months of life

Australia's RSV Maternal and Infant Protection Program is delivering beardown extortion for babies, with caller probe from The Kids Research Institute Australia showing RSV vaccination fixed during gestation reduces the hazard of RSV-related hospitalization by much than 80% during an infant's archetypal six months of life.